Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor β-dependent manner: A new contributor to HCV-induced oxidative stress

Journal of Virology

Volumn 83, Issue 24, 2009, Pages 12934-12946

  Boudreau, Howard E ^a   Emerson, Suzanne U ^a   Korzeniowska, Agnieszka ^a   Jendrysik, Meghan A ^a   Leto, Thomas L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENTARY DNA; CORE PROTEIN; LUCIFERASE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SHORT HAIRPIN RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME SYNTHESIS; GENE EXPRESSION; GENETIC TRANSFECTION; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPORTER GENE; TRANSCRIPTION REGULATION; VIRUS INDUCTION; VIRUS REPLICATION;

ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEP G2 CELLS; HEPACIVIRUS; HUMANS; MICE; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDES; TRANSFORMING GROWTH FACTOR BETA; VIRAL PROTEINS;

HEPATITIS C VIRUS; MURINAE;

EID: 72849147487     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01059-09     Document Type: Article

References (75)

1. Basu, A., K. Meyer, K. K. Lai, K. Saito, A. M. Di Bisceglie, L. E. Grosso, R. B. Ray, and R. Ray. 2006. Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes. Virology 349:347-358.
2. Battaglia, S., N. Benzoubir, S. Nobilet, P. Charneau, D. Samuel, A. L. Zignego, A. Atfi, C. Brechot, and M. F. Bourgeade. 2009. Liver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumor suppression to epithelial-mesenchymal transition. PLoS ONE 4:e4355.
3. Bedard, K., and K. H. Krause. 2007. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87:245-313.
4. Blight, K. J., J. A. McKeating, and C. M. Rice. 2002. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76:13001-13014.
5. Block, K., A. Eid, K. K. Griendling, D. Y. Lee, Y. Wittrant, and Y. Gorin. 2008. Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression. J. Biol. Chem. 283:24061-24076.
6. Budhu, A., Y. Chen, J. W. Kim, M. Forgues, K. Valerie, C. C. Harris, and X. W. Wang. 2007. Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins. Carcinogenesis 28:1552-1560.
7. Bureau, C., J. Bernad, N. Chaouche, C. Orfila, M. Beraud, C. Gonindard, L. Alric, J. P. Vinel, and B. Pipy. 2001. Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J. Biol. Chem. 276:23077-23083.
8. Chan, S. W., and P. A. Egan. 2005. Hepatitis C virus envelope proteins regulate CHOP via induction of the unfolded protein response. FASEB J. 19:1510-1512.
9. Chen, K., M. T. Kirber, H. Xiao, Y. Yang, and J. F. Keaney, Jr. 2008. Regulation of ROS signal transduction by NADPH oxidase 4 localization. J. Cell Biol. 181:1129-1139.
10. Chiang, E., O. Dang, K. Anderson, A. Matsuzawa, H. Ichijo, and M. David. 2006. Cutting edge: apoptosis-regulating signal kinase 1 is required for reactive oxygen species-mediated activation of IFN regulatory factor 3 by lipopolysaccharide. J. Immunol. 176:5720-5724.
11. Choi, J., and J. H. Ou. 2006. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G847-G851.
12. Choi, S. H., and S. B. Hwang. 2006. Modulation of the transforming growth factor-beta signal transduction pathway by hepatitis C virus nonstructural 5A protein. J. Biol. Chem. 281:7468-7478.
13. Ciccaglione, A. R., C. Marcantonio, E. Tritarelli, P. Tataseo, A. Ferraris, R. Bruni, B. Dallapiccola, G. Gerosolimo, A. Costantino, and M. Rapicetta. 2008. Microarray analysis identifies a common set of cellular genes modulated by different HCV replicon clones. BMC Genomics 9:309.
14. Cucoranu, I., R. Clempus, A. Dikalova, P. J. Phelan, S. Ariyan, S. Dikalov, and D. Sorescu. 2005. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res. 97:900-907.
15. De Minicis, S., and D. A. Brenner. 2007. NOX in liver fibrosis. Arch. Biochem. Biophys. 462:266-272.
16. Dou, J., P. Liu, and X. Zhang. 2005. Cellular response to gene expression profiles of different hepatitis C virus core proteins in the Huh-7 cell line with microarray analysis. J. Nanosci. Nanotechnol. 5:1230-1235.
17. Dubuisson, J. 2007. Hepatitis C virus proteins. World J. Gastroenterol. 13:2406-2415.
18. Farinati, F., R. Cardin, M. Bortolami, M. Guido, and M. Rugge. 2006. Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis. World J. Gastroenterol. 12: 2065-2069.
19. Farinati, F., R. Cardin, N. De Maria, G. Della Libera, C. Marafin, E. Lecis, P. Burra, A. Floreani, A. Cecchetto, and R. Naccarato. 1995. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J. Hepatol. 22:449-456.
20. Gabriel, A., A. Ziolkowski, P. Radlowski, K. Tomaszek, and A. Dziambor. 2008. Hepatocyte steatosis in HCV patients promotes fibrosis by enhancing TGF-beta liver expression. Hepatol. Res. 38:141-146.
21. Garcia-Mediavilla, M. V., S. Sanchez-Campos, P. Gonzalez-Perez, M. Gomez-Gonzalo, P. L. Majano, M. Lopez-Cabrera, G. Clemente, C. Garcia-Monzon, and J. Gonzalez-Gallego. 2005. Differential contribution of hepatitis C virus NS5A and core proteins to the induction of oxidative and nitrosative stress in human hepatocyte-derived cells. J. Hepatol. 43:606-613.
22. Geiszt, M., J. B. Kopp, P. Varnai, and T. L. Leto. 2000. Identification of renox, an NAD(P)H oxidase in kidney. Proc. Natl. Acad. Sci. USA 97:8010-8014.
23. Geiszt, M., and T. L. Leto. 2004. The Nox family of NAD(P)H oxidases: host defense and beyond. J. Biol. Chem. 279:51715-51718.
24. Giannini, C., and C. Brechot. 2003. Hepatitis C virus biology. Cell Death Differ. 10(Suppl. 1):S27-S38.
25. Gong, G., G. Waris, R. Tanveer, and A. Siddiqui. 2001. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc. Natl. Acad. Sci. USA 98:9599-9604.
26. Hassan, M., D. Selimovic, H. Ghozlan, and O. Abdel-kader. 2009. Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways. Hepatology 49:1469-1482.
27. He, Y., S. L. Tan, S. U. Tareen, S. Vijaysri, J. O. Langland, B. L. Jacobs, and M. G. Katze. 2001. Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A. J. Virol. 75:5090-5098.
28. Ismail, S., A. Sturrock, P. Wu, B. Cahill, K. Norman, T. Huecksteadt, K. Sanders, T. Kennedy, and J. Hoidal. 2009. NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3. Am. J. Physiol. Lung Cell. Mol. Physiol. 296:L489-L499.
29. Jain, S. K., P. W. Pemberton, A. Smith, R. F. McMahon, P. C. Burrows, A. Aboutwerat, and T. W. Warnes. 2002. Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J. Hepatol. 36:805-811.
30. Kaimori, A., J. Potter, J. Y. Kaimori, C. Wang, E. Mezey, and A. Koteish. 2007. Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J. Biol. Chem. 282:22089-22101.
31. Kanzler, S., M. Baumann, P. Schirmacher, V. Dries, E. Bayer, G. Gerken, H. P. Dienes, and A. W. Lohse. 2001. Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta. J. Viral Hepat. 8:430-437.
32. Kim, K. H., S. P. Hong, K. Kim, M. J. Park, K. J. Kim, and J. Cheong. 2007. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. Biochem. Biophys. Res. Commun. 355:883-888.
33. Koike, K. 2006. Oxidative stress and apoptosis in hepatitis C: the core issue. J. Gastroenterol. 41:292-294.
34. Koike, K., and H. Miyoshi. 2006. Oxidative stress and hepatitis C viral infection. Hepatol. Res. 34:65-73.
35. Korenaga, M., T. Wang, Y. Li, L. A. Showalter, T. Chan, J. Sun, and S. A. Weinman. 2005. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J. Biol. Chem. 280:37481-37488.
36. Larrea, E., A. Alberdi, Y. Castelruiz, P. Boya, M. P. Civeira, and J. Prieto. 2001. Expression of interferon-alpha subtypes in peripheral mononuclear cells from patients with chronic hepatitis C: a role for interferon-alpha5. J. Viral Hepat. 8:103-110.
37. Liao, Q. J., L. B. Ye, K. A. Timani, Y. L. She, X. J. Yang, L. Ye, and Z. H. Wu. 2005. Hepatitis C virus non-structural 5A protein can enhance full-length core protein-induced nuclear factor-kappaB activation. World J. Gastroenterol. 11:6433-6439.
38. Macdonald, A., K. Crowder, A. Street, C. McCormick, K. Saksela, and M. Harris. 2003. The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signaling. J. Biol. Chem. 278:17775-17784.
39. Mahadev, K., H. Motoshima, X. Wu, J. M. Ruddy, R. S. Arnold, G. Cheng, J. D. Lambeth, and B. J. Goldstein. 2004. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol. Cell. Biol. 24:1844-1854.
40. Marek, B., D. Kajdaniuk, U. Mazurek, E. Janczewska-Kazek, B. Kos-Kudla, B. Strzalka, A. Fila, D. Niedziolka, M. Beniowski, Z. Ostrowska, H. Borgiel-Marek, J. Kajdaniuk, L. Sieminska, M. Nowak, T. Wilczok, D. Pakula, and P. Filipczyk. 2005. TGF-beta1 mRNA expression in liver biopsy specimens and TGF-beta1 serum levels in patients with chronic hepatitis C before and after antiviral therapy. J. Clin. Pharm. Ther. 30:271-277.
41. Martyn, K. D., L. M. Frederick, K. von Loehneysen, M. C. Dinauer, and U. G. Knaus. 2006. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell. Signal. 18:69-82.
42. Mas, V. R., D. G. Maluf, K. J. Archer, K. Yanek, X. Kong, L. Kulik, C. E. Freise, K. M. Olthoff, R. M. Ghobrial, P. McIver, and R. Fisher. 2009. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol. Med. 15:85-94.
43. Mengshol, J. A., L. Golden-Mason, and H. R. Rosen. 2007. Mechanisms of disease: HCV-induced liver injury. Nat. Clin. Pract. Gastroenterol. Hepatol. 4:622-634.
44. Moradpour, D., F. Penin, and C. M. Rice. 2007. Replication of hepatitis C virus. Nat. Rev. Microbiol. 5:453-463.
45. Moriya, K., H. Fujie, Y. Shintani, H. Yotsuyanagi, T. Tsutsumi, K. Ishibashi, Y. Matsuura, S. Kimura, T. Miyamura, and K. Koike. 1998. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 4:1065-1067.
46. Moriya, K., K. Nakagawa, T. Santa, Y. Shintani, H. Fujie, H. Miyoshi, T. Tsutsumi, T. Miyazawa, K. Ishibashi, T. Horie, K. Imai, T. Todoroki, S. Kimura, and K. Koike. 2001. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res. 61:4365-4370.
47. Moriya, K., H. Yotsuyanagi, Y. Shintani, H. Fujie, K. Ishibashi, Y. Matsuura, T. Miyamura, and K. Koike. 1997. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J. Gen. Virol. 78(Pt. 7):1527-1531.
48. Nguyen, H., S. Sankaran, and S. Dandekar. 2006. Hepatitis C virus core protein induces expression of genes regulating immune evasion and antiapoptosis in hepatocytes. Virology 354:58-68.
49. Nishikawa, T., T. Nakajima, T. Katagishi, Y. Okada, M. Jo, K. Kagawa, T. Okanoue, Y. Itoh, and T. Yoshikawa. 2009. Oxidative stress may enhance the malignant potential of human hepatocellular carcinoma by telomerase activation. Liver Int. 29:846-856.
50. Okuda, M., K. Li, M. R. Beard, L. A. Showalter, F. Scholle, S. M. Lemon, and S. A. Weinman. 2002. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122:366-375.
51. Park, H. S., H. Y. Jung, E. Y. Park, J. Kim, W. J. Lee, and Y. S. Bae. 2004. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J. Immunol. 173:3589-3593.
52. Patel, D. N., S. R. Bailey, J. K. Gresham, D. B. Schuchman, J. H. Shelhamer, B. J. Goldstein, B. M. Foxwell, M. B. Stemerman, J. K. Maranchie, A. J. Valente, S. Mummidi, and B. Chandrasekar. 2006. TLR4-NOX4-AP-1 signaling mediates lipopolysaccharide-induced CXCR6 expression in human aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 347:1113-1120.
53. Pedruzzi, E., C. Guichard, V. Ollivier, F. Driss, M. Fay, C. Prunet, J. C. Marie, C. Pouzet, M. Samadi, C. Elbim, Y. O'Dowd, M. Bens, A. Vandewalle, M. A. Gougerot-Pocidalo, G. Lizard, and E. Ogier-Denis. 2004. NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol. Cell. Biol. 24:10703-10717.
54. Poli, G. 2000. Pathogenesis of liver fibrosis: role of oxidative stress. Mol. Aspects Med. 21:49-98.
55. Russell, R. S., J. C. Meunier, S. Takikawa, K. Faulk, R. E. Engle, J. Bukh, R. H. Purcell, and S. U. Emerson. 2008. Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus. Proc. Natl. Acad. Sci. USA 105:4370-4375.
56. Saito, K., K. Meyer, R. Warner, A. Basu, R. B. Ray, and R. Ray. 2006. Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein. J. Virol. 80:4372-4379.
57. Sato, Y., J. Kato, R. Takimoto, K. Takada, Y. Kawano, K. Miyanishi, M. Kobune, T. Takayama, T. Matunaga, and Y. Niitsu. 2006. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB. Gut 55:1801-1808.
58. Seronello, S., M. Y. Sheikh, and J. Choi. 2007. Redox regulation of hepatitis C in nonalcoholic and alcoholic liver. Free Radic. Biol. Med. 43:869-882.
59. Shin, J. Y., W. Hur, J. S. Wang, J. W. Jang, C. W. Kim, S. H. Bae, S. K. Jang, S. H. Yang, Y. C. Sung, O. J. Kwon, and S. K. Yoon. 2005. HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1. Exp. Mol. Med. 37:138-145.
60. Shiose, A., J. Kuroda, K. Tsuruya, M. Hirai, H. Hirakata, S. Naito, M. Hattori, Y. Sakaki, and H. Sumimoto. 2001. A novel superoxide-producing NAD(P)H oxidase in kidney. J. Biol. Chem. 276:1417-1423.
61. Shirai, Y., S. Kawata, S. Tamura, N. Ito, H. Tsushima, K. Takaishi, S. Kiso, and Y. Matsuzawa. 1994. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases. Cancer 73:2275-2279.
62. Sturrock, A., T. P. Huecksteadt, K. Norman, K. Sanders, T. M. Murphy, P. Chitano, K. Wilson, J. R. Hoidal, and T. P. Kennedy. 2007. Nox4 mediates TGF-beta1-induced retinoblastoma protein phosphorylation, proliferation, and hypertrophy in human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 292:L1543-L1555.
63. Sumpter, R., Jr., Y. M. Loo, E. Foy, K. Li, M. Yoneyama, T. Fujita, S. M. Lemon, and M. Gale, Jr. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79:2689-2699.
64. Taniguchi, H., N. Kato, M. Otsuka, T. Goto, H. Yoshida, Y. Shiratori, and M. Omata. 2004. Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription. J. Med. Virol. 72:52-59.
65. Thoren, F., A. Romero, M. Lindh, C. Dahlgren, and K. Hellstrand. 2004. A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals. J. Leukoc. Biol. 76:1180-1186.
66. Tsutsumi, T., T. Suzuki, K. Moriya, H. Yotsuyanagi, Y. Shintani, H. Fujie, Y. Matsuura, S. Kimura, K. Koike, and T. Miyamura. 2002. Alteration of intrahepatic cytokine expression and AP-1 activation in transgenic mice expressing hepatitis C virus core protein. Virology 304:415-424.
67. Ueberham, E., R. Low, U. Ueberham, K. Schonig, H. Bujard, and R. Gebhardt. 2003. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology 37:1067-1078.
68. Verma, V., A. Chakravarti, and P. Kar. 2008. Cytokine levels of TGF-beta, IL-10, and sTNFalphaRII in type C chronic liver disease. Dig. Dis. Sci. 53:2233-2237.
69. von Lohneysen, K., D. Noack, A. J. Jesaitis, M. C. Dinauer, and U. G. Knaus. 2008. Mutational analysis reveals distinct features of the Nox4-p22 phox complex. J. Biol. Chem. 283:35273-35282.
70. Walters, K. A., A. J. Syder, S. L. Lederer, D. L. Diamond, B. Paeper, C. M. Rice, and M. G. Katze. 2009. Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes. PLoS Pathog. 5:e1000269.
71. Wieser, R., L. Attisano, J. L. Wrana, and J. Massague. 1993. Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region. Mol. Cell. Biol. 13:7239-7247.
72. Wu, R. F., Z. Ma, D. P. Myers, and L. S. Terada. 2007. HIV-1 Tat activates dual Nox pathways leading to independent activation of ERK and JNK MAP kinases. J. Biol. Chem. 282:37412-37419.
73. Xu, J., S. Lamouille, and R. Derynck. 2009. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19:156-172.
74. Yanagi, M., R. H. Purcell, S. U. Emerson, and J. Bukh. 1997. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc. Natl. Acad. Sci. USA 94:8738-8743.
75. Zeisberg, M., C. Yang, M. Martino, M. B. Duncan, F. Rieder, H. Tanjore, and R. Kalluri. 2007. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 282:23337-23347.